Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses
- PMID: 17143722
- PMCID: PMC1892610
- DOI: 10.1007/s11262-006-0050-3
Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses
Abstract
In this article we describe two new complete genomic sequences of Old World Arenaviruses: the Mopeia (MOP) virus and the reassortant MOP/LAS virus, clone 29, or ML29. This reassortant has the large (L) RNA from MOP virus and the small (S) RNA from Lassa (LAS) virus, Josiah strain. Recent studies showed that the ML29 virus is not pathogenic for mice, guinea pigs, or macaques, can completely protect guinea pigs from Lassa virus, and elicit vigorous cell-mediated immunity in immunized monkeys (Lukashevich, I. S., Patterson, J., Carrion, R., Moshkoff, D., Ticer, A., Zapata, J., Brasky, K., Geiger, R., Hubbard, G. B., Bryant, J., and Salvato, M. S., J Virol 79, 13934-13942, 2005). This is a molecular characterization of a reassortant virus, which has been put forward as a live attenuated vaccine candidate against Lassa Fever. Sequence analysis of this reassortant virus revealed 5 non-conservative amino acid substitutions that distinguished it from the parental LAS and MOP viruses. Three substitutions were found outside the conserved RNA-dependent RNA polymerase (RdRp) motifs. A fourth substitution was located between the glycoprotein (GPC)-cleavage site and the putative fusion peptide of GP2. The nucleocapsid protein (NP) contained a fifth substitution in the carboxyl-terminal region of the protein. Two mutations were found within each non-coding terminus of the L segment and one mutation was located in the 3' non-coding region of the S segment of the MOP/LAS virus. ML29 mutations in its genomic termini may have implications for the genetic stability and replication efficiency of ML29 reassortant.
Figures





Similar articles
-
Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.J Virol. 2014 Mar;88(6):3058-66. doi: 10.1128/JVI.03035-13. Epub 2013 Dec 11. J Virol. 2014. PMID: 24335292 Free PMC article.
-
A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.J Virol. 2005 Nov;79(22):13934-42. doi: 10.1128/JVI.79.22.13934-13942.2005. J Virol. 2005. PMID: 16254329 Free PMC article.
-
Generation of reassortants between African arenaviruses.Virology. 1992 Jun;188(2):600-5. doi: 10.1016/0042-6822(92)90514-p. Virology. 1992. PMID: 1585636
-
Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.NPJ Vaccines. 2018 Mar 20;3:11. doi: 10.1038/s41541-018-0049-5. eCollection 2018. NPJ Vaccines. 2018. PMID: 29581897 Free PMC article. Review.
-
Recombination and gene coding assignments of bunyaviruses and arenaviruses.Ann N Y Acad Sci. 1980;354:84-106. doi: 10.1111/j.1749-6632.1980.tb27960.x. Ann N Y Acad Sci. 1980. PMID: 7013623 Review. No abstract available.
Cited by
-
An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity.Virol J. 2013 Feb 12;10:52. doi: 10.1186/1743-422X-10-52. Virol J. 2013. PMID: 23402317 Free PMC article.
-
Arenavirus variations due to host-specific adaptation.Viruses. 2013 Jan 17;5(1):241-78. doi: 10.3390/v5010241. Viruses. 2013. PMID: 23344562 Free PMC article. Review.
-
Current research for a vaccine against Lassa hemorrhagic fever virus.Drug Des Devel Ther. 2018 Aug 14;12:2519-2527. doi: 10.2147/DDDT.S147276. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30147299 Free PMC article. Review.
-
Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.J Virol. 2014 Mar;88(6):3058-66. doi: 10.1128/JVI.03035-13. Epub 2013 Dec 11. J Virol. 2014. PMID: 24335292 Free PMC article.
-
Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.Antiviral Res. 2011 Nov;92(2):125-38. doi: 10.1016/j.antiviral.2011.07.015. Epub 2011 Jul 27. Antiviral Res. 2011. PMID: 21820469 Free PMC article. Review.
References
-
- Salvato MS, Clegg JCS, Buchmeier MJ, Charrel RN, Gonzalez J-P, Lukashevich IS, Rico-Hesse R, Romanowski V. In: Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, editors. Elsevier/Academic Press; London: 2005. pp. 725–733.
-
- Johnson KM, Taylor P, Elliott LH, Tomori O. Am J Trop Med Hyg. 1981;30:1291–1293. - PubMed
-
- Walker DH, Johnson KM, Lange JV, Gardner JJ, Kiley MP, McCormick JB. J Infect Dis. 1982;146:360–368. - PubMed
-
- Lukashevich IS, Vasiuchkov AD, Stel’makh TA, Scheslenok EP, Shabanov AG. Vopr Virusol. 1991;36:146–150. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous